You have 9 free searches left this month | for more free features.

Ebselen

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ototoxicity Trial in Charleston (Placebo, SPI-1005 Ebselen 200mg Capsule x1, SPI-1005 Ebselen 200mg Capsule x2)

Enrolling by invitation
  • Ototoxicity
  • Placebo
  • +3 more
  • Charleston, South Carolina
    Medical University of South Carolina
Dec 7, 2022

Depressive Disorder, Treatment-Resistant Trial in Oxford (Ebselen, Placebo)

Recruiting
  • Depressive Disorder, Treatment-Resistant
  • Ebselen
  • Placebo
  • Oxford, Oxfordshire, United Kingdom
    Neurosciences Building, Dept. Psychiatry, Warneford Hospital
Dec 15, 2021

Covid19, Coronavirus, Coronavirus Infection Trial in United States (Ebselen, Placebo)

Enrolling by invitation
  • Covid19
  • +3 more
  • Ebselen
  • Placebo
  • New Haven, Connecticut
  • +6 more
Apr 5, 2022

Covid19, Corona Virus Infection, Coronavirus Trial in United States (Ebselen, Placebo)

Enrolling by invitation
  • Covid19
  • +3 more
  • Ebselen
  • Placebo
  • New Haven, Connecticut
  • +6 more
Apr 5, 2022

Meniere Disease, Ménière Trial in United States (Ebselen, Placebo)

Recruiting
  • Meniere Disease
  • Ménière
  • Ebselen
  • Placebo
  • Little Rock, Arkansas
  • +14 more
Jan 3, 2023

Meniere's Disease Trial in United States (200mg SPI-1005 BID, 400mg SPI-1005 BID, Placebo)

Completed
  • Meniere's Disease
  • 200mg SPI-1005 BID
  • +2 more
  • Fresno, California
  • +12 more
Mar 15, 2021

Meniere's Disease Trial in United States (SPI-1005)

Completed
  • Meniere's Disease
  • Los Angeles, California
  • +4 more
Mar 15, 2021

Bipolar Disorder, Bipolar Disorder, Manic Trial in Oxford (Ebselen, Placebo oral capsule)

Completed
  • Bipolar Disorder
  • Bipolar Disorder, Manic
  • Ebselen
  • Placebo oral capsule
  • Oxford, Oxfordshire, United Kingdom
    Neurosciences Building, Dept. Psychiatry, Warneford Hospital
Sep 5, 2019

Brain Aneurysms: Utility of Cisternal Urokinase Irrigation

Completed
  • Subarachnoid Hemorrhage, Aneurysmal
  • +2 more
  • Valencia, Spain
    Hospital General Universitario de Valencia
Mar 7, 2021

Lung Cancer, Head Neck Cancer, Hearing Loss Trial in Seattle (SPI-1005 Low Dose, SPI-1005 Middle Dose, SPI-1005 High Dose)

Unknown status
  • Lung Cancer
  • +5 more
  • SPI-1005 Low Dose
  • +3 more
  • Seattle, Washington
    VA Puget Sound Health Care
Sep 21, 2017

Noise Induced Hearing Loss Trial in United States (SPI-1005 200mg, SPI-1005 400mg, Placebo)

Unknown status
  • Noise Induced Hearing Loss
  • SPI-1005 200mg
  • +2 more
  • Miami, Florida
  • +4 more
Aug 22, 2018

Hearing Loss, Cancer Trial in Lincoln (SPI-1005, Placebo)

Completed
  • Hearing Loss
  • Cancer
  • Lincoln, Nebraska
    MDS Pharma Services
Jun 27, 2016

Temporary Auditory Threshold Shift Trial in Gainsville (SPI-1005 Low dose, SPI-1005 Middle dose, SPI-1005 High dose)

Completed
  • Temporary Auditory Threshold Shift
  • SPI-1005 Low dose
  • +3 more
  • Gainsville, Florida
    University of Florida
Aug 26, 2014

Type 1 Diabetes, Type 2 Diabetes Trial in Boston (Ebselen, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • Type 2 Diabetes Mellitus
  • Ebselen
  • Placebo
  • Boston, Massachusetts
    Brigham and Women's Hosptial
Sep 29, 2008